Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition
- PMID: 26321261
- PMCID: PMC4673910
- DOI: 10.1016/S0140-6736(15)61340-X
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition
Abstract
Background: The Global Burden of Disease Study 2013 (GBD 2013) aims to bring together all available epidemiological data using a coherent measurement framework, standardised estimation methods, and transparent data sources to enable comparisons of health loss over time and across causes, age-sex groups, and countries. The GBD can be used to generate summary measures such as disability-adjusted life-years (DALYs) and healthy life expectancy (HALE) that make possible comparative assessments of broad epidemiological patterns across countries and time. These summary measures can also be used to quantify the component of variation in epidemiology that is related to sociodemographic development.
Methods: We used the published GBD 2013 data for age-specific mortality, years of life lost due to premature mortality (YLLs), and years lived with disability (YLDs) to calculate DALYs and HALE for 1990, 1995, 2000, 2005, 2010, and 2013 for 188 countries. We calculated HALE using the Sullivan method; 95% uncertainty intervals (UIs) represent uncertainty in age-specific death rates and YLDs per person for each country, age, sex, and year. We estimated DALYs for 306 causes for each country as the sum of YLLs and YLDs; 95% UIs represent uncertainty in YLL and YLD rates. We quantified patterns of the epidemiological transition with a composite indicator of sociodemographic status, which we constructed from income per person, average years of schooling after age 15 years, and the total fertility rate and mean age of the population. We applied hierarchical regression to DALY rates by cause across countries to decompose variance related to the sociodemographic status variable, country, and time.
Findings: Worldwide, from 1990 to 2013, life expectancy at birth rose by 6·2 years (95% UI 5·6-6·6), from 65·3 years (65·0-65·6) in 1990 to 71·5 years (71·0-71·9) in 2013, HALE at birth rose by 5·4 years (4·9-5·8), from 56·9 years (54·5-59·1) to 62·3 years (59·7-64·8), total DALYs fell by 3·6% (0·3-7·4), and age-standardised DALY rates per 100 000 people fell by 26·7% (24·6-29·1). For communicable, maternal, neonatal, and nutritional disorders, global DALY numbers, crude rates, and age-standardised rates have all declined between 1990 and 2013, whereas for non-communicable diseases, global DALYs have been increasing, DALY rates have remained nearly constant, and age-standardised DALY rates declined during the same period. From 2005 to 2013, the number of DALYs increased for most specific non-communicable diseases, including cardiovascular diseases and neoplasms, in addition to dengue, food-borne trematodes, and leishmaniasis; DALYs decreased for nearly all other causes. By 2013, the five leading causes of DALYs were ischaemic heart disease, lower respiratory infections, cerebrovascular disease, low back and neck pain, and road injuries. Sociodemographic status explained more than 50% of the variance between countries and over time for diarrhoea, lower respiratory infections, and other common infectious diseases; maternal disorders; neonatal disorders; nutritional deficiencies; other communicable, maternal, neonatal, and nutritional diseases; musculoskeletal disorders; and other non-communicable diseases. However, sociodemographic status explained less than 10% of the variance in DALY rates for cardiovascular diseases; chronic respiratory diseases; cirrhosis; diabetes, urogenital, blood, and endocrine diseases; unintentional injuries; and self-harm and interpersonal violence. Predictably, increased sociodemographic status was associated with a shift in burden from YLLs to YLDs, driven by declines in YLLs and increases in YLDs from musculoskeletal disorders, neurological disorders, and mental and substance use disorders. In most country-specific estimates, the increase in life expectancy was greater than that in HALE. Leading causes of DALYs are highly variable across countries.
Interpretation: Global health is improving. Population growth and ageing have driven up numbers of DALYs, but crude rates have remained relatively constant, showing that progress in health does not mean fewer demands on health systems. The notion of an epidemiological transition--in which increasing sociodemographic status brings structured change in disease burden--is useful, but there is tremendous variation in burden of disease that is not associated with sociodemographic status. This further underscores the need for country-specific assessments of DALYs and HALE to appropriately inform health policy decisions and attendant actions.
Funding: Bill & Melinda Gates Foundation.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Figures
Comment in
-
A transition towards a healthier global population?Lancet. 2015 Nov 28;386(10009):2121-2. doi: 10.1016/S0140-6736(15)61476-3. Epub 2015 Aug 26. Lancet. 2015. PMID: 26318267 No abstract available.
-
Species loss: learn from health metrics.Nature. 2016 Oct 20;538(7625):371. doi: 10.1038/538317d. Nature. 2016. PMID: 27762358 No abstract available.
Similar articles
-
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17. Lancet. 2024. PMID: 38642570 Free PMC article.
-
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.Lancet. 2018 Nov 10;392(10159):1859-1922. doi: 10.1016/S0140-6736(18)32335-3. Lancet. 2018. PMID: 30415748 Free PMC article.
-
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.Lancet. 2016 Oct 8;388(10053):1603-1658. doi: 10.1016/S0140-6736(16)31460-X. Lancet. 2016. PMID: 27733283 Free PMC article.
-
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Lancet. 2015 Aug 22;386(9995):743-800. doi: 10.1016/S0140-6736(15)60692-4. Epub 2015 Jun 7. Lancet. 2015. PMID: 26063472 Free PMC article. Review.
-
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.Lancet. 2013 Nov 9;382(9904):1575-86. doi: 10.1016/S0140-6736(13)61611-6. Epub 2013 Aug 29. Lancet. 2013. PMID: 23993280 Review.
Cited by
-
The societal costs of avoidant personality disorder.Personal Ment Health. 2025 Feb;19(1):e1644. doi: 10.1002/pmh.1644. Personal Ment Health. 2025. PMID: 39572388 Free PMC article.
-
Transcranial Direct Current Stimulation Combined With Repetitive Transcranial Magnetic Stimulation for Depression: A Randomized Clinical Trial.JAMA Netw Open. 2024 Nov 4;7(11):e2444306. doi: 10.1001/jamanetworkopen.2024.44306. JAMA Netw Open. 2024. PMID: 39535797 Free PMC article. Clinical Trial.
-
Laboratory validation of a clinical metagenomic next-generation sequencing assay for respiratory virus detection and discovery.Nat Commun. 2024 Nov 12;15(1):9016. doi: 10.1038/s41467-024-51470-y. Nat Commun. 2024. PMID: 39532844 Free PMC article.
-
Feasibility of knee magnetic resonance imaging protocol using artificial intelligence-assisted iterative algorithm protocols: comparison with standard MRI protocols.Front Med (Lausanne). 2024 Oct 23;11:1480196. doi: 10.3389/fmed.2024.1480196. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39507702 Free PMC article.
-
ECG data analysis to determine ST-segment elevation myocardial infarction and infarction territory type: an integrative approach of artificial intelligence and clinical guidelines.Front Physiol. 2024 Oct 7;15:1462847. doi: 10.3389/fphys.2024.1462847. eCollection 2024. Front Physiol. 2024. PMID: 39434722 Free PMC article.
References
-
- Global Burden of Disease Study 2013 Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743–800. - PMC - PubMed
-
- Alliance NCD . Healthy planet, healthy people: The NCD alliance vision for health in the post-2015 development agenda. NCD Alliance; Geneva: 2013.
-
- [accessed Feb 9, 2015];Open working group proposal for Sustainable development goals. 2014 ent https://sustainabledevelopment.un.org/index.php?page=view&type=400&nr=15....
-
- Pintér L, Almássy D, Hatakeyama S. Sustainable Development Goals and indicators for a small planet—Part II: Measuring sustainability. Asia-Europe Foundation; Singapore: 2014.
Publication types
MeSH terms
Grants and funding
- T32 HL007093/HL/NHLBI NIH HHS/United States
- MR/L003120/1/MRC_/Medical Research Council/United Kingdom
- CDF-2013-06-012/DH_/Department of Health/United Kingdom
- 100715/WT_/Wellcome Trust/United Kingdom
- 099876/WT_/Wellcome Trust/United Kingdom
- MR/K006525/1/MRC_/Medical Research Council/United Kingdom
- 092654/WT_/Wellcome Trust/United Kingdom
- WT_/Wellcome Trust/United Kingdom
- 089963/WT_/Wellcome Trust/United Kingdom
- RP-PG-0407-10184/DH_/Department of Health/United Kingdom
- P30 DK056338/DK/NIDDK NIH HHS/United States
- RG/08/014/24067/BHF_/British Heart Foundation/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
